Clinical Trial Update: A Study of the Efficacy and Safety of Tocilizumab in Adults With Rheumatoid Arthritis. [Phase 3]

View source ↗

Summary

Phase 3 trial update on the efficacy and safety of tocilizumab in adults with rheumatoid arthritis; the study is completed and results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Tocilizumab (tocilizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2017-03-06